| Literature DB >> 33418977 |
Martin Maronek1, Barbora Gromova1, Robert Liptak2, Barbora Konecna1, Michal Pastorek1, Barbora Cechova3, Maria Harsanyova4,5, Jaroslav Budis5,6,7, David Smolak4,5, Jan Radvanszky5,6,8, Tomas Szemes4,5,6, Jana Harsanyiova9, Alzbeta Kralova Trancikova10, Roman Gardlik1.
Abstract
Circulating extracellular DNA (ecDNA) is known to worsen the outcome of many diseases. ecDNA released from neutrophils during infection or inflammation is present in the form of neutrophil extracellular traps (NETs). It has been shown that higher ecDNA concentration occurs in a number of inflammatory diseases including inflammatory bowel disease (IBD). Enzymes such as peptidyl arginine deiminases (PADs) are crucial for NET formation. We sought to describe the dynamics of ecDNA concentrations and fragmentation, along with NETosis during a mouse model of chemically induced colitis. Plasma ecDNA concentration was highest on day seven of dextran sulfate sodium (DSS) intake and the increase was time-dependent. This increase correlated with the percentage of cells undergoing NETosis and other markers of disease activity. Relative proportion of nuclear ecDNA increased towards more severe colitis; however, absolute amount decreased. In colon explant medium, the highest concentration of ecDNA was on day three of DSS consumption. Early administration of PAD4 inhibitors did not alleviate disease activity, but lowered the ecDNA concentration. These results uncover the biological characteristics of ecDNA in IBD and support the role of ecDNA in intestinal inflammation. The therapeutic intervention aimed at NETs and/or nuclear ecDNA has yet to be fully investigated.Entities:
Keywords: PAD4; cell-free DNA; deoxyribonuclease activity; neutrophil extracellular traps; ulcerative colitis
Year: 2021 PMID: 33418977 DOI: 10.3390/cells10010081
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600